WormBase Tree Display for RNAi: WBRNAi00071046

WBRNAi00071046 Homol: Homol_homol: K02A11:RNAi
  Sequence_info: PCR_product: sjj_K02A11.1
  Experiment: Laboratory: RT
    Date: 16 Jul 2007 00:00:00
    Genotype: bIs1(vit-2::GFP); rrf-3(pk1426)
    Temperature: 20
    Delivered_by: Bacterial_feeding
  Inhibits: Predicted_gene: K02A11.1b Inferred_automatically: RNAi_primary
      K02A11.1a Inferred_automatically: RNAi_primary
    Gene: WBGene00001582 Inferred_automatically: RNAi_primary
    Transcript: K02A11.1a.3 Inferred_automatically: RNAi_primary
      K02A11.1b.2 Inferred_automatically: RNAi_primary
      K02A11.1a.5 Inferred_automatically: RNAi_primary
      K02A11.1a.2 Inferred_automatically: RNAi_primary
      K02A11.1a.1 Inferred_automatically: RNAi_primary
      K02A11.1b.1 Inferred_automatically: RNAi_primary
      K02A11.1a.4 Inferred_automatically: RNAi_primary
  Species: Caenorhabditis elegans
  Reference: WBPaper00030951
  Phenotype: WBPhenotype:0000961 Remark: RNAi treatment resulted in an abnormal accumulation of YP170-GFP in the body cavity.
    WBPhenotype:0001425 Remark: RNAi treatment resulted in weak suppression of yolk uptake by oocytes as judged by the abnormal accumulation of YP170-GFP in the body cavity.
  Remark: Primary screen. L1 larval stage was applied to induced RNAi cultures.
  Method: RNAi